The Senate on Health, Education, Employment and Retirement Pensions (Help) voted Thursday morning to advance President Donald Trump’s choice for the presidency of the National Institutes of Health, Dr. Jay Bahtasharia.
The vote was accurately on partisan lines, 12 votes in favor and 11 votes, but with one additional Republican member in the majority, Bhaterea sailed to the finish line with the support of the Republican Party only. Bhattacharlya is now heading to the full Senate to obtain an imminent confirmation vote that will be the last obstacle before becoming the next director of the National Informatics Institutes.
Senator Bernie Sanders, I-VT, expressed their concern on Thursday about the assertion of Bahtasharia, saying that he is afraid that he will not do Bhathsharia enough to help reduce the cost of prescribed medications. Sanders and other Democrats have also expressed concern about how Bahtasharia dealt with medical research at the National Institutes of Health, especially given that Trump imposed only the maximum of facilities and management costs related to NIH research grants.
The doctor, a professor of medicine at Stanford and his oldest colleague at the University Economic Policy Research Institute, was a pioneering voice during the Covid-19s against the closure measures and vaccine delegations.
Jayanta Bhatertharia, the candidate for President Donald Trump to be the director of the National Institutes of Health, is speaking in the assertion session before the Senate, Education, Labor, and pensions in Capitol Hill on March 5, 2025 in Washington, DC. (Andrew Harnik/Getty Emiez)
Bhattacharlya has been examined by the Senate Assistance Committee almost a week ago on various issues related to its potential role as director of the National Institutes of Health; However, a lot of the session was forced to defend the president’s decision to put 15 % Cap at indirect search costs Disconcilated by the National Institutes of Health.
Bhaterea does not explicitly say that he does not agree to discounts, or that, if confirmed, he interferes to stop them. Instead, he said that the law “will be followed”, with an investigation also in the impact of discounts and ensuring that each of the National Health Institutes of Health is a job that progresses on the health results of the Americans of the necessary resources.
In addition to dealing with questions about Trump discounts, Bhaterea also developed what he called a new, decentralized vision for the future Research in the National Institutes of Health He said that he would aim to adopt opposition and transparency ideas, with a focus on research topics that have the best opportunity to benefit directly from the health results of the Americans. Bhattacharlya added that he wants to rid the agency’s research portfolio for other “trivial” efforts that he says is only a little to benefit directly from the health results.
“I think what matters mainly: Do scientists have the idea of progressing the scientific field in which they are?” Bhatersia said last week during the confirmation certificate. “Do they have an idea that ends the treatment Health needs Who are the Americans? “
Jayanta Bhattacharya witnesses during the American Senate Committee on Health, Education, Work and Retirement Pensions to be nominated to be the director of the National Institutes of Health (NIH), in Capitol Hill in Washington, DC, on March 5, 2025.
Bhattacharlya was significantly a co-author of the Great Brington Declaration, which was a document published in October 2020 by a group of scientists calling for an alternative approach to dealing with the Covid-19s. He has significantly argued against the lock and enhances the effectiveness of the natural immunity of the virus for low -risk individuals, indicating that the vaccine may not be the best path to work for everyone.
Click here to get the Fox News app
Before his confirmation sessions, Bhattacharlya, along with many other scientists, including Trump’s choice of the Head of Food and Drug Administration, Dr. Marti Macari, A new research magazine launched Focus on stimulating scientific discourse and combating “preservation of the gate” in the medical research community. The magazine, which is titled the Journal of Public Health Academy (JAPH), is implementing a new approach aimed at stimulating the scientific discourse by publishing peer reviews of prominent studies from other magazines that do not make peer reviews available to the public.
